167 related articles for article (PubMed ID: 9770764)
1. Matrix metalloproteinases 2 and 9 in canine rheumatoid arthritis.
Coughlan AR; Robertson DH; Bennett D; May C; Beynon RJ; Carter SD
Vet Rec; 1998 Aug; 143(8):219-23. PubMed ID: 9770764
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases 2 and 9 in equine synovial fluids.
Clegg PD; Coughlan AR; Riggs CM; Carter SD
Equine Vet J; 1997 Sep; 29(5):343-8. PubMed ID: 9306059
[TBL] [Abstract][Full Text] [Related]
3. A study of metalloproteinases in fifty joint fluid specimens.
Gaudin P; Razakaboay M; Surla A; Berthier S; Fauconnier J; Morel F; Phelip X
Rev Rhum Engl Ed; 1997 Jun; 64(6):375-81. PubMed ID: 9513609
[TBL] [Abstract][Full Text] [Related]
4. Synovial fluid matrix metalloproteinase-2 and -9 activities in dogs suffering from joint disorders.
Murakami K; Maeda S; Yonezawa T; Matsuki N
J Vet Med Sci; 2016 Jul; 78(6):1051-4. PubMed ID: 26902805
[TBL] [Abstract][Full Text] [Related]
5. Zymographic analysis using gelatin-coated film of the effect of etanercept on the extracellular matrix-degrading activity in synovial fluids of rheumatoid arthritis patients.
Kamataki A; Ishida M; Komagamine M; Yoshida M; Ando T; Sawai T
Int J Rheum Dis; 2016 Apr; 19(4):385-91. PubMed ID: 24618272
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies of a 92-kDa gelatinolytic metalloproteinase from U937 cells and matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts.
Morodomi T; Suzuki K; Sasaguri Y; Morimatsu M; Nagase H
Matrix Suppl; 1992; 1():87-8. PubMed ID: 1480100
[No Abstract] [Full Text] [Related]
7. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
[TBL] [Abstract][Full Text] [Related]
8. Activation of progelatinase B in synovial fluids of patients with rheumatoid arthritis, with reference to stromelysin-1 and tissue inhibitor of matrix metalloproteinase-1.
Watanabe Y; Yamaguchi R; IwakiEgawa S; Shimamori Y; Fujimoto Y; Matsuno H
Clin Exp Rheumatol; 1999; 17(4):401-6. PubMed ID: 10464548
[TBL] [Abstract][Full Text] [Related]
9. Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis.
Hegemann N; Wondimu A; Ullrich K; Schmidt MF
Vet Immunol Immunopathol; 2003 Feb; 91(3-4):199-204. PubMed ID: 12586482
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases 2 and 9 activity in bovine synovial fluids.
Arican M; Coughlan AR; Clegg PD; Carter SD
J Vet Med A Physiol Pathol Clin Med; 2000 Oct; 47(8):449-56. PubMed ID: 11075535
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity.
Paemen L; Martens E; Masure S; Opdenakker G
Eur J Biochem; 1995 Dec; 234(3):759-65. PubMed ID: 8575432
[TBL] [Abstract][Full Text] [Related]
12. Rheumatoid synovial endothelial cells secrete decreased levels of tissue inhibitor of MMP (TIMP1).
Jackson CJ; Arkell J; Nguyen M
Ann Rheum Dis; 1998 Mar; 57(3):158-61. PubMed ID: 9640131
[TBL] [Abstract][Full Text] [Related]
13. Determination of MMP-2 and -9 activities in synovial fluid of horses with osteoarthritic and arthritic joint diseases using gelatin zymography and immunocapture activity assays.
Fietz S; Einspanier R; Hoppner S; Hertsch B; Bondzio A
Equine Vet J; 2008 May; 40(3):266-71. PubMed ID: 18089467
[TBL] [Abstract][Full Text] [Related]
14. In situ gelatinolytic activity correlates with tumor progression and prognosis in patients with bladder cancer.
Kawamura K; Kamiya N; Suyama T; Shimbo M; Oosumi N; Suzuki H; Ueda T; Tobe T; Igarashi T; Ito H; Ishikura H
J Urol; 2004 Oct; 172(4 Pt 1):1480-4. PubMed ID: 15371875
[TBL] [Abstract][Full Text] [Related]
15. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis.
Maeda S; Sawai T; Uzuki M; Takahashi Y; Omoto H; Seki M; Sakurai M
Ann Rheum Dis; 1995 Dec; 54(12):970-5. PubMed ID: 8546529
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
17. Expression of matrix metalloproteinase-9 (gelatinase B) in gouty arthritis and stimulation of MMP-9 by urate crystals in macrophages.
Hsieh MS; Ho HC; Chou DT; Pan S; Liang YC; Hsieh TY; Lan JL; Tsai SH
J Cell Biochem; 2003 Jul; 89(4):791-9. PubMed ID: 12858344
[TBL] [Abstract][Full Text] [Related]
18. Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandibular disorder.
Kubota T; Kubota E; Matsumoto A; Kawai Y; Saito H; Mikuni-Takagaki Y; Sato S
Eur J Oral Sci; 1998 Dec; 106(6):992-8. PubMed ID: 9879910
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase protein expression profiles cannot distinguish between normal and early osteoarthritic synovial fluid.
Heard BJ; Martin L; Rattner JB; Frank CB; Hart DA; Krawetz R
BMC Musculoskelet Disord; 2012 Jul; 13():126. PubMed ID: 22824140
[TBL] [Abstract][Full Text] [Related]
20. The activation and function of host matrix metalloproteinases in dentin matrix breakdown in caries lesions.
Tjäderhane L; Larjava H; Sorsa T; Uitto VJ; Larmas M; Salo T
J Dent Res; 1998 Aug; 77(8):1622-9. PubMed ID: 9719036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
